DEA Nods to Lab's Bid for Controlled Drug Production
Published Date: 7/17/2025
Notice
Summary
Cerilliant Corporation wants to get official permission to make large amounts of certain controlled substances. This affects anyone who works with these drugs, like researchers and medicine makers. If approved, Cerilliant can start producing soon, helping labs get the materials they need without delays or extra costs.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Cerilliant Seeks Bulk Manufacturer Registration
Cerilliant Corporation has applied to be registered as a bulk manufacturer of certain controlled substances. If approved, Cerilliant could produce large quantities of those drugs, which the notice says would help researchers, laboratories, and medicine makers get the materials they need without delays or extra costs.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in